𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes

✍ Scribed by Susanna A. Möller; Ralph A. Reisfeld


Publisher
Springer-Verlag
Year
1991
Tongue
English
Weight
948 KB
Volume
33
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Inhibition of bispecific monoclonal anti
✍ Cor H. J. Lamers; Jan W. Gratama; Sven O. Warnaar; Gerrit Stoter; Reinder L. H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 743 KB

T lymphocytes of 8 patients with ovarian cancer were targeted to the tumor cells using F(ab')2 fragments of a bispecific monoclonal antibody (bsAb), specific for CD3 (a component of the T lymphocyte receptor for antigen) and for the folate receptor MOv I 8 (overexpressed by ovarian carcinoma cells)

Activation of mononuclear cells to be us
✍ S. M. Pupa; S. Canevari; R. Fontanelli; S. Ménard; D. Mezzanzanica; A. Lanzavecc 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 French ⚖ 624 KB

Recently we reported that cytotoxic T-cell clones can be retar eted to unrelated tumor cells by bispecific monoclonal antbodies (MAbs), anti-CDJ and anti-ovarian carcinoma (cuOCl TR) (Mezzanzanica eta/., 1988). In the perspective of in vivo tumor immunotherapy, as an alternative to cytotoxic T lymph

Lysis of tumor cells by the retargeting
✍ I. G. Barr; H. R. Macdonald; F. Buchegger; V. Von Fliedner 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 652 KB

The specificity and efficiency of tumor-cell lysis by the retargeting of murine cytolytic lymphocytes (CTL) with bispecific antibodies was examined. Bispecific antibodies (also known as heteroaggregated or hybrid antibodies) were produced by the chemical coupling of monoclonal antibodies (MAbs) agai

The LFA-1/ICAM cell adhesion pathway is
✍ Silvano Ferrini; Sabrina Sforzini; Anna Cambiaggi; Alessandro Poggi; Raffaella M 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 752 KB

We investigated the role of the LFA-I /ICAM, VLA-4/VCAM-I and CD2/LFAJ adhesion pathways in the cytolysis of tumor cells mediated by an anti-EGF-R/anti-CD3 bispecific monoclonal antibody (biMAb). The biMAb induced efficient lysis of